Trial will evaluate whether Mavenclad can slow the rate of upper limb disability progression

CGRP antagonist approved to prevent migraine in adults with episodic and chronic migraine

New findings from phase 2 study published in The Lancet

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Researchers have identified three drugs, already approved for other uses in humans, as possible therapeutics for COVID-19, the […]

Monitoring how patients with multiple sclerosis or other degenerative diseases use their smartphones could provide valuable information to […]